Bacil Pharma Limited (BOM:524516)

Bacil Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	5.69	28.57	0.41	0.29	2.3
Trading Asset Securities	-	-	-	1.91	0.76
Cash & Short-Term Investments	5.69	28.57	0.41	2.2	3.06
Cash Growth	-80.10%	6788.85%	-81.12%	-28.26%	28.71%
Accounts Receivable	11.8	-	-	-	-
Receivables	11.8	-	-	-	-
Other Current Assets	0.05	0.5	0.11	0.09	0.1
Total Current Assets	17.53	29.07	0.52	2.29	3.16
Property, Plant & Equipment	-	-	0.06	0.08	0.11
Long-Term Investments	242.4	213.57	6.11	2.36	2.36
Long-Term Deferred Tax Assets	6.19	0.54	0.56	1.17	1.08
Other Long-Term Assets	-0	0	-	0	-0
Total Assets	273.93	256	13.26	11.27	12.72

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	0.2	0.04	0.04	0	0.11
Accrued Expenses	23.81	-	0.09	0.06	0.02
Short-Term Debt	-	1.64	0.98	0.21	0.33
Other Current Liabilities	1.8	0.01	0.02	0.01	0.02
Total Current Liabilities	25.8	1.69	1.13	0.28	0.47
Other Long-Term Liabilities	-0	0	-	0	-
Total Liabilities	25.8	1.69	1.13	0.28	0.47

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	139.7	139.7	58.9	58.9	58.9
Retained Earnings	108.42	114.61	-53.14	-54.28	-53.03
Comprehensive Income & Other	-	-	6.37	6.37	6.37
Shareholders' Equity	248.13	254.31	12.13	10.99	12.24
Total Liabilities & Equity	273.93	256	13.26	11.27	12.72

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	-	1.64	0.98	0.21	0.33
Net Cash (Debt)	5.69	26.93	-0.57	1.99	2.73
Net Cash Growth	-78.89%	-	-	-27.11%	338.69%
Net Cash Per Share	0.41	4.27	-0.10	0.33	0.46
Filing Date Shares Outstanding	14.13	14.35	5.89	5.89	5.89
Total Common Shares Outstanding	14.13	14.35	5.89	5.89	5.89
Working Capital	-8.27	27.39	-0.61	2.01	2.69
Book Value Per Share	17.56	17.72	2.06	1.87	2.08
Tangible Book Value	248.13	254.31	12.13	10.99	12.24
Tangible Book Value Per Share	17.56	17.72	2.06	1.87	2.08
Machinery	-	0.59	0.55	0.59	0.59

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error